| | 
Part, Chapter, Paragraph
1 II, 5. 3. 2 | CRs. They usually perform ad hoc studies on representative
2 II, 5. 3. 7 | difficult to address with ad hoc budgetary solutions).~·
3 II, 5. 4. 1 | relies on the conduction of ad hoc studies that are often
4 II, 5. 4. 2 | granting access to a range of ad hoc services.~Information
5 II, 5. 4. 8 | 2006; 74:S200-S204.~Morris AD, Boyle DI, MacAlpine R,
6 II, 5. 5.Acr | Acronyms~ ~AD~Alzheimer’s Disease~ESEMeD~
7 II, 5. 5.Int(17)| Lopez AD, Mathers CD, Ezzati M, Jamison
8 II, 5. 5.Int | of Alzheimer’s Disease (AD) increase in women but not
9 II, 5. 5.Int | noted that the rates of AD were higher among women
10 II, 5. 5. 3 | version 2007~Murray CJL, Lopez AD (2000): Progress and directions
11 II, 5. 5. 3 | Psychiatry 64:733 –735.~Sadovnick AD, Ebers GC (1993): Epidemiology
12 II, 5. 6. 2 | Musculoskeletal Health)~· Woolf AD, Pfleger B Burden of Osteoporosis
13 II, 5. 6. 6 | Res Int 4:161-169~Lopez AD, Mathers CD, Ezzati M, Jamison
14 II, 5. 6. 6 | Reid DM, Rowe R, Woolf AD, Wallace WA (2001): Incidence
15 II, 5. 6. 6 | Intern Med 117:801-806~Woolf AD (2000): The bone and joint
16 II, 5. 6. 6 | Rheum Dis 59:81-82~Woolf AD (2007): What healthcare
17 II, 5. 6. 6 | Rheum Dis. 66:281-282~Woolf AD (2008): Economic Burden
18 II, 5. 6. 6 | Harris ED). Elsevier,~Woolf AD, Akesson K (2003): Preventing
19 II, 5. 6. 6 | people. BMJ 327:89-95~Woolf AD, Pfleger B (2005): Burden
20 II, 5. 6. 6 | Osteoporos Rep 3:84-91~Woolf AD, Zeidler H, Haglund U, Carr
21 II, 5. 6. 6 | Rheum Dis 63:342-347~Woolf AD and Pfleger B (2003): Burden
22 II, 5. 6. 6 | Organ 81(9):646-56~Woolf AD and Akesson K (2006): The
23 II, 5. 7. 7 | M, Vander Hoorn S, Lopez AD, Lin RB, Murray CJ (2004):
24 II, 5. 8. 7 | 100: 1973-1980.~ ~Mohangoo AD, van der Linden MW, Schellevis
25 II, 5. 8. 7 | 105.~ ~Murray CJ, Lopez AD (1997): Alternative projections
26 II, 5. 9. 7 | Allergic rhinitis and asthma ad hoc survey: clinical and
27 II, 8. 1. 2 | LFS), based on a special ad hoc module, was carried
28 II, 8. 1. 6 | statistical analysis of the lfs ad hoc module and the eu-silc. [
29 II, 8. 2. 2 | statistical analysis of the LFS ad hoc module and the EU-SILC.
30 II, 8. 2. 2 | Murray CJL, Lopez AD, Mathers CD, Stein C (2001):
31 II, 8. 2. 3 | statistical analysis of the LFS ad hoc module and the EU-SILC.
32 II, 9. 4. 3 | of Alzheimer’s Disease (AD) increased in women but
33 II, 9. 4. 3 | noted that the rates of AD were higher among women
34 II, 9. 4. 8 | 9.4.8. Acronyms~ ~AD~Alzheimer’s Disease~AIDS~
35 II, 9. 5. 7 | 9.5.7. Acronyms~ ~AD~Alzheimer’s Disease~EIWH~
36 III, 10. 1. 3 | 10/2005~Ezzati M, Lopez AD, Rodgers A, Hoorn S van
37 III, 10. 2. 1 | at http ~ ~Keil U, Liese AD, Hense HW, et al Classical
38 III, 10. 2. 1 | and Health; 1: 5.~ ~Lopez AD, Collishaw NE, Piha T (1994):
39 III, 10. 2. 1 | at: htt ~ ~Peto R, Lopez AD, Boreham J, Thun M (2005)
40 III, 10. 2. 1 | possible impact by means of an ad hoc consultation in 2008.~ ~
41 III, 10. 2. 1 | Edited by: Ezzati M, Lopez AD, Rodgers A, Murray CJL.):
42 III, 10. 4. 2 | and on http ~ ~An ad hoc methodology to assess
43 III, 10. 4. 2 | accessible to measurements. An ad hoc scientific Colloquium
44 III, 10. 5. 3 | standard survey so called ad hoc modules are included.
45 III, 10. 5. 3 | outdated. A repetition of the ad hoc module was planned for
46 IV, 12. 7 | Policies in Brussels produced ad hoc publications in 2002
47 IV, 12. 7 | systems impact assessment~An ad hoc Working Group of the
48 IV, 12. 10 | many national reports and ad hoc documents available
49 IV, 13. 9 | such data.~Ezzati M, Lopez AD, Rodgers A, Hoorn S van
|
|
| |
